Cardiovascular
-
Cardiovascular
First Heart Failure Patient Treated With Impulse Dynamics' CCM Therapy in Brazil
The Optimizer delivers cardiac contractility modulation therapy, the company’s proprietary technology, to the heart.Business Wire 01.21.21
-
Cardiovascular
Boston Scientific to Acquire Preventice for Up to $925M
Acquisition of external cardiac monitoring technologies, services provider to expand rhythm management diagnostics portfolio.PR Newswire 01.21.21
-
Cardiovascular | Surgical
Haemonetics to Acquire Cardiva for Up to $510M
Enhances penetration into the large and growing interventional cardiology and electrophysiology markets.PR Newswire 01.20.21
-
Cardiovascular | Surgical
Abbott Wins Expanded Medicare Coverage for MitraClip
Includes patients with secondary (or functional) mitral regurgitation resulting from heart failure.Abbott Laboratories 01.20.21
-
Cardiovascular | Patient Monitoring
Hillrom to Buy Bardy Diagnostics for $375M
Advances digital health offering with expansion into attractive ambulatory cardiac monitoring segment.PR Newswire 01.19.21
-
Cardiovascular
Occlutech's Atrial Flow Regulator Earns Breakthrough Status for HF
First-in-class, implantable Atrial Flow Regulator (AFR) for heart failure (HF) patients.PR Newswire 01.19.21
-
Cardiovascular | Diagnostics
FDA OKs MRI for Impulse Dynamics' Optimizer CCM Delivery Systems
FDA clears potential hurdle for many heart failure patients.Business Wire 01.19.21
-
Cardiovascular
FineHeart Successfully Tests Wireless TET System
A breakthrough in treating patients with severe heart failure.FineHeart 01.18.21
-
Cardiovascular
U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
The use of TAVR over open surgical techniques for replacing an aortic valve has exploded globally in recent years.GlobalData 01.15.21
-
Cardiovascular
WhiteSwell Issued Patent for Treatment of Acute Decompensated Heart Failure
Company adds to portfolio of 40 patents for catheter-based technology that leverages the power of the body’s natural fluid removal process.Business Wire 01.13.21
-
Cardiovascular
Acutus Medical Launches AcQCross Transseptal System in Europe
The product is designed to improve safety and efficiency in any procedure requiring left heart access.Globe Newswire 01.08.21
-
Cardiovascular | Electronics
Medtech Matters: A Non-Contact ECG Sensor
MPO's Sean Fenske speaks with Dr. Jesse Wheeler of Draper about the R&D organization’s project involving non-contact ECG monitoring.Sean Fenske, Editor-in-Chief 01.05.21
-
Cardiovascular | Neurological | Surgical
FDA OKs Rapid Medical's Steerable Neurovascular Guidewire
Provides efficient access in difficult neuro and peripheral vascular procedures.Business Wire 01.04.21
-
Cardiovascular
Edwards Treats First Patient in Restore Clinical Trial
Evaluates minimally invasive device for mitral valve disease.Edwards Lifesciences Corp. 12.21.20
-
Cardiovascular | Diagnostics
Genetesis' CardioFlux Imaging Tech Gains Breakthrough Status
Leverages room temperature magnetometers to noninvasively measure heart’s naturally-generated magnetic fields.Business Wire 12.16.20
-
Cardiovascular
Pandemic May Hinder Growth in Peripheral Drug-Coated Balloon Market
Percutaneous transluminal angioplasty balloon procedures declined by almost 30 percent in 2020.GlobalData 12.15.20
-
Cardiovascular | Surgical
Foldax Earns FDA Approval for Biopolymer Mitral Heart Valve Study
Valve designs intended to resist calcification, withstand stresses and strains without failure.Business Wire 12.14.20
-
Cardiovascular
Innovative Health Obtains Patent for Microlumen Reprocessing Technology
Paves the way for future innovation in the field by the company.Innovative Health Inc. 12.11.20
-
Cardiovascular | Patient Monitoring
FDA OKs Volta Medical's VX1 AI AFib Mapping Software
Assists in real-time manual annotation of 3D anatomical, electrical maps of the atria during AFib.PR Newswire 12.10.20
-
Cardiovascular
Abbott Launches OCT Virtual Reality Training for Cardiologists
VR training improved cath lab staff learning engagement by 45 percent, knowledge retention by 72 percent.Abbott Laboratories 12.09.20
